![Christopher Sarchi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Sarchi
Företagsledare/Principal på
BICARA THERAPEUTICS INC.
Förmögenhet: 2 M $ per 2026-05-31
Profil
Christopher Sarchi is currently Chief Commercial Officer at Bicara Therapeutics, Inc. since 2026 and Chief Commercial Officer at Replimune Group, Inc. since 2022.
Former positions include Director-Oncology Regional Sales at Genentech, Inc. from 2010 to 2013 and Head-Commercial Oncology US Region at Sanofi.
Education includes undergraduate studies at the University of Maine.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
REPLIMUNE GROUP, INC. 0,23 % | 2026-06-01 | 180 962 ( 0,23 % ) | 2 M $ | 2026-05-31 |
Aktiva positioner av Christopher Sarchi
| Företag | Position | Start |
|---|---|---|
| BICARA THERAPEUTICS INC. | Företagsledare/Principal | 2026-05-08 |
Tidigare kända positioner av Christopher Sarchi
| Företag | Position | Slut |
|---|---|---|
| REPLIMUNE GROUP, INC. | Företagsledare/Principal | 2026-05-01 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | 2013-01-01 |
| SANOFI | Företagsledare/Principal | - |
Christopher Sarchis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
46
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of Maine
 University of Maine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Bicara Therapeutics, Inc.
 Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors | Health Technology |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
